Continuum Advisory’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-1,171
Closed -$110K 609
2025
Q1
$110K Buy
1,171
+278
+31% +$24.9K 0.01% 503
2024
Q4
$81.2K Buy
893
+131
+17% +$12.5K 0.01% 564
2024
Q3
$69.7K Buy
762
+368
+93% +$37.5K 0.01% 586
2024
Q2
$38.2K Buy
394
+125
+46% +$11.5K 0.01% 659
2024
Q1
$25.3K Buy
+269
New +$22.8K ﹤0.01% 740

Other funds holding CL

Continuum Advisory's CL Position: Q2 2025 in Review

Continuum Advisory sold out of Colgate-Palmolive (CL) in Q2 2025, closing a stake of 1,171 shares — an estimated $110K sold.

Continuum Advisory first reported a position in CL in Q1 2024 and held it in 5 quarters. The position peaked at $110K in Q1 2025. 1,913 funds tracked by Wall St. Rank hold CL as of Q2 2025.

  • Continuum Advisory reported no remaining Colgate-Palmolive position as of Q2 2025 after selling out during the quarter.
  • Continuum Advisory sold 1,171 Colgate-Palmolive shares in Q2 2025, an estimated $110K.
  • Continuum Advisory first reported a position in Colgate-Palmolive in Q1 2024 and held it in 5 quarters.
  • Continuum Advisory's Colgate-Palmolive position peaked at $110K in Q1 2025.
  • 1,913 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2025.

Based on Continuum Advisory's 13F filing for Q2 2025, filed 13 Aug 2025.